These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
174 related items for PubMed ID: 12573802
1. Expression of mRNA for PACAP and its receptors in intra- and extra-adrenal human pheochromocytomas and their relationship to catecholamine synthesis. Isobe K, Tatsuno I, Yashiro T, Nanmoku T, Takekoshi K, Kawakami Y, Nakai T. Regul Pept; 2003 Feb 28; 110(3):213-7. PubMed ID: 12573802 [Abstract] [Full Text] [Related]
2. Expression of mRNAs for PACAP and its receptor in human neuroblastomas and their relationship to catecholamine synthesis. Isobe K, Kaneko M, Kaneko S, Nissato S, Nanmoku T, Takekoshi K, Okuda Y, Kawakami Y. Regul Pept; 2004 Dec 15; 123(1-3):29-32. PubMed ID: 15518890 [Abstract] [Full Text] [Related]
7. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Reubi JC, Läderach U, Waser B, Gebbers JO, Robberecht P, Laissue JA. Cancer Res; 2000 Jun 01; 60(11):3105-12. PubMed ID: 10850463 [Abstract] [Full Text] [Related]
8. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals. Alexandre D, Anouar Y, Jegou S, Fournier A, Vaudry H. Endocrinology; 1999 Mar 01; 140(3):1285-93. PubMed ID: 10067855 [Abstract] [Full Text] [Related]
9. Expression of trophic amidated peptides and their receptors in benign and malignant pheochromocytomas: high expression of adrenomedullin RDC1 receptor and implication in tumoral cell survival. Thouënnon E, Pierre A, Tanguy Y, Guillemot J, Manecka DL, Guérin M, Ouafik L, Muresan M, Klein M, Bertherat J, Lefebvre H, Plouin PF, Yon L, Anouar Y. Endocr Relat Cancer; 2010 Sep 01; 17(3):637-51. PubMed ID: 20483910 [Abstract] [Full Text] [Related]
13. The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor. Sano H, Miyata A, Horio T, Nishikimi T, Matsuo H, Kangawa K. Regul Pept; 2002 Nov 15; 109(1-3):107-13. PubMed ID: 12409222 [Abstract] [Full Text] [Related]
17. Pituitary adenylate-cyclase-activating polypeptide (PACAP) binding sites and PACAP/vasoactive intestinal polypeptide receptor expression in human pituitary adenomas. Oka H, Jin L, Reubi JC, Qian X, Scheithauer BW, Fujii K, Kameya T, Lloyd RV. Am J Pathol; 1998 Dec 15; 153(6):1787-96. PubMed ID: 9846969 [Abstract] [Full Text] [Related]
18. Hypophysiotropic action of pituitary adenylate cyclase-activating polypeptide (PACAP) in the goldfish: immunohistochemical demonstration of PACAP in the pituitary, PACAP stimulation of growth hormone release from pituitary cells, and molecular cloning of pituitary type I PACAP receptor. Wong AO, Leung MY, Shea WL, Tse LY, Chang JP, Chow BK. Endocrinology; 1998 Aug 15; 139(8):3465-79. PubMed ID: 9681497 [Abstract] [Full Text] [Related]
19. Distribution of mRNAs for pituitary adenylate cyclase-activating polypeptide (PACAP), PACAP receptor, vasoactive intestinal polypeptide (VIP), and VIP receptors in the rat superior cervical ganglion. Nogi H, Hashimoto H, Hagihara N, Shimada S, Yamamoto K, Matsuda T, Tohyama M, Baba A. Neurosci Lett; 1997 May 09; 227(1):37-40. PubMed ID: 9178853 [Abstract] [Full Text] [Related]
20. [Physiological significance of pituitary adenylate cyclase-activating polypeptide (PACAP) in the nervous system]. Hashimoto H. Yakugaku Zasshi; 2002 Dec 09; 122(12):1109-21. PubMed ID: 12510388 [Abstract] [Full Text] [Related] Page: [Next] [New Search]